ELI LILLY & Co Logo

ELI LILLY & Co

Pharma leader developing medicines for diabetes, obesity, oncology, and neuroscience.

LLY | US

Overview

Corporate Details

ISIN(s):
US5324571083
LEI:
Country:
United States of America
Address:
LILLY CORPORATE CTR, 46285 INDIANAPOLIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eli Lilly and Company is a global pharmaceutical corporation engaged in the discovery, development, manufacturing, and commercialization of human healthcare products. Founded in 1876, the company has a long history of medical innovation, focusing on creating medicines for significant health challenges. Its portfolio primarily targets non-communicable diseases, with key therapeutic areas including diabetes, oncology, immunology, and neuroscience. Lilly is widely recognized for its pioneering role in diabetes care and has more recently become a prominent leader in the development of novel therapies for obesity and related metabolic conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ELI LILLY & Co filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ELI LILLY & Co

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ELI LILLY & Co via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Sarepta Therapeutics, Inc. Logo
Develops precision genetic medicines for rare neuromuscular disorders.
United States of America SRPT
Savara Inc Logo
Clinical-stage biopharma developing inhaled therapies for rare respiratory diseases.
United States of America SVRA
SAWAI GROUP HOLDINGS Co., Ltd. Logo
A leading Japanese generic drug maker expanding into digital health and wellness solutions.
Japan 4887
Scandion Oncology A/S Logo
Biotech company in liquidation, formerly developing therapies to overcome cancer drug resistance.
Denmark SCOL
Scholar Rock Holding Corp Logo
Biopharma developing medicines for neuromuscular diseases by targeting protein growth factors.
United States of America SRRK
Scienture Holdings, Inc. Logo
Develops and commercializes specialty drugs for unmet medical needs, focusing on CNS disorders.
United States of America SCNX
Scilex Holding Co Logo
Develops and commercializes non-opioid products for acute and chronic pain management.
United States of America SCLX
Scinai Immunotherapeutics Ltd. Logo
Dual-model biopharma: developing NanoAbs for I&I and offering CDMO services.
United States of America SCNI
SciSparc Ltd. Logo
Developing cannabinoid-based therapies for central nervous system (CNS) disorders.
United States of America SPRC
Develops high-purity stem cell therapies for incurable immunological and inflammatory diseases.
South Korea 298060

Talk to a Data Expert

Have a question? We'll get back to you promptly.